Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
59,822,943
-
Shares change
-
+5,664,007
-
Total reported value, excl. options
-
$208,780,865
-
Value change
-
+$27,504,263
-
Put/Call ratio
-
90%
-
Number of buys
-
62
-
Number of sells
-
-54
-
Price
-
$3.49
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2020
142 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q2 2020.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,822,943 shares
.
Largest 10 shareholders include BlackRock Inc. (5,616,562 shares), Avoro Capital Advisors LLC (5,250,000 shares), D. E. Shaw & Co., Inc. (3,385,172 shares), VANGUARD GROUP INC (3,380,375 shares), Foresite Capital Management IV, LLC (2,843,893 shares), CITADEL ADVISORS LLC (2,700,098 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,500,000 shares), Sio Capital Management, LLC (2,299,982 shares), Vivo Capital, LLC (2,089,356 shares), and BOXER CAPITAL, LLC (2,000,000 shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.